10 Jun 2019 16:08
Cathay International Holdings Limited
("Cathay" or the "Company")
Results of Annual General Meeting ("AGM")
Hong Kong, 10 June 2019 - Cathay International Holdings Limited (LSE: CTI.L), an operator and investor in the growing healthcare sector in the People's Republic of China, today announces that at the AGM held earlier today, all resolutions as set out in the Notice of AGM dated 17 April 2019 were duly passed. The final poll voting results for each resolution are shown in the table below:
Ordinary resolutions | For | Against | Total votes | Withheld |
1. Report and Accounts | 441,697,339 | 141,975 | 441,839,314 | 1,920 |
2. Re-election of Mr. Lee Jin-Yi as Executive Director | 441,695,587 | 138,639 | 441,834,226 | 7,008 |
3. Re-election of Mr. Siu Ka Chi Eric as Executive Director | 441,695,587 | 138,639 | 441,834,226 | 7,008 |
4. Re-election of Mr. Patrick Sung as Executive Director | 441,695,587 | 138,639 | 441,834,226 | 7,008 |
5. Re-election of Dr. Chan Ching Har Eliza as Independent Non-Executive Director | 441,695,587 | 138,639 | 441,834,226 | 7,008 |
6. Reappointment of BDO as Auditor | 441,823,380 | 15,954 | 441,839,334 | 1,900 |
7. Authority to allot new shares | 441,696,508 | 139,618 | 441,836,126 | 5,108 |
Special resolutions | For | Against | Total votes | Withheld |
8. Disapplication of pre-emption rights | 441,691,580 | 144,618 | 441,836,126 | 5,108 |
9. Authority to purchase own shares | 441,829,408 | 9,926 | 441,839,334 | 1,900 |
Notes:
1. Any proxy votes which are at the discretion of the Chairman have been included in the 'For' total.
2. A vote 'Withheld' is not a vote in law and is not counted in the calculation of the proportion of the votes for and against a resolution.
3. In accordance with the UK Listing Rules only the votes of the holders of Common Shares were actually counted in the voting on resolution number 5. A majority of the votes of the holders of Common Shares were received in favour of this resolution which was duly passed. Out of a total of 372,289,238 votes of holders of Common Shares, 276,529,104 votes were received in favour of this resolution, 34,263 votes were at the discretion of the Chairman, 132,059 votes were against and 3,088 votes were withheld.
The proxy figures for the resolutions will also be displayed on the Company website at www.cathay-intl.com.hk
- ENDS -
For further enquiries, please contact:
Cathay International Holdings Limited Eric Siu (Finance Director) Patrick Sung (Director and Controller)
|
Tel: +852 2828 9289 |
Consilium Strategic Communications Mary-Jane Elliott / Matthew Neal / Lindsey Neville
|
Tel: +44 (0) 203 709 5702
|
About Cathay
Cathay International Holdings Limited (LSE: CTI.L) is a main market listed investment holding company and an operator and investor in the healthcare sector in the People's Republic of China (the "PRC"). The Company and its subsidiaries (collectively the "Group") aim to leverage on investment opportunities in the growing domestic demand for high quality healthcare products in the PRC and build portfolio companies into market sector leaders with competitive edge. Cathay has already demonstrated a track record of identifying investment opportunities in this area including: Lansen, a leading specialty pharmaceutical company focused on rheumatology and dermatology in the PRC; Haizi, a company engaged in the manufacture, marketing and sale of inositol and its by-product, dicalcium phosphate; Natural Dailyhealth, a company engaged in production and sales of plant extracts for use as key active ingredients in healthcare products; and Botai, a company engaged in collagen products.
The Group employs approximately 1,500 people across the PRC, including over 20 specialist corporate and business development staff based at the holding company's offices in Hong Kong and Shenzhen. Cathay also has a hotel investment. For more information please visit the Company's website: www.cathay-intl.com.hk.